Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure.

Abstract:

:Gastric and intestinal phenotypic expression in 37 surgically obtained primary signet ring cell carcinomas, five of their metastases to lymph nodes, and three signet ring cell carcinomas transplanted into nude mice were determined by biochemical, mucin, histochemical, and ultrastructural studies. Crude extracts of cancer tissues were used for measurements of pepsinogen isozymes, sucrase, aminopeptidase (microsomal), and alkaline phosphatase. Histochemical staining of mucin by paradoxical concanavalin A, the galactose oxidase-Schiff sequence and sialidase-galactose oxidase-Schiff, and the periodate-borohydride technique/potassium hydroxide/periodic acid-Schiff procedure was performed. The procedures allowed clear definition of pyloric gland, surface mucous, small and large intestinal goblet, and intestinal absorptive cell types. Of 40 specimens examined, 19 consisted entirely of gastric-type cells, and three entirely of intestinal-type cells. The others consisted of mixtures of gastric and intestinal-type cells. The observed high incidence of intestinal-type cells in signet ring cell carcinomas suggested that intestinal-type cells develop independently from intestinal metaplasia within signet ring cell carcinomas (diffuse-type gastric cancers), which probably originate from nonmetaplastic gastric mucosa.

journal_name

Cancer Res

journal_title

Cancer research

authors

Tatematsu M,Furihata C,Katsuyama T,Miki K,Honda H,Konishi Y,Ito N

subject

Has Abstract

pub_date

1986-09-01 00:00:00

pages

4866-72

issue

9

eissn

0008-5472

issn

1538-7445

journal_volume

46

pub_type

杂志文章
  • Navitoclax (ABT-263) accelerates apoptosis during drug-induced mitotic arrest by antagonizing Bcl-xL.

    abstract::Combining microtubule-targeting antimitotic drugs with targeted apoptosis potentiators is a promising new chemotherapeutic strategy to treat cancer. In this study, we investigate the cellular mechanism by which navitoclax (previously called ABT-263), a Bcl-2 family inhibitor, potentiates apoptosis triggered by paclita...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4336

    authors: Shi J,Zhou Y,Huang HC,Mitchison TJ

    更新日期:2011-07-01 00:00:00

  • Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.

    abstract::HeLa cells were synchronized at the G1-S boundary by double thymidine block and treated for 1 hr with varying concentrations of the antibiotic anticancer protein neocarzinostatin (NCS). Cells were then released from the block and allowed to resume their cycle. Aliquots were removed at various times in order to monitor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berry DE,Collins JM

    更新日期:1980-07-01 00:00:00

  • CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.

    abstract::Other than an association with HPV infection, little is known about the genetic alterations determining the development of penile cancer. Although penile cancer is rare in the developed world, it presents a significant burden in developing countries. Here, we report the findings of whole-exome sequencing (WES) to dete...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3134

    authors: Feber A,Worth DC,Chakravarthy A,de Winter P,Shah K,Arya M,Saqib M,Nigam R,Malone PR,Tan WS,Rodney S,Freeman A,Jameson C,Wilson GA,Powles T,Beck S,Fenton T,Sharp TV,Muneer A,Kelly JD

    更新日期:2016-08-15 00:00:00

  • Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

    abstract::There are now more than 10 million cancer survivors in the United States. With these numbers, chronic sequelae that result from cancer therapy have become a major health care problem. Although radiation therapy of the brain has improved cancer cure rates, learning disorders and memory deficits are a common consequence...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6327

    authors: Thotala DK,Hallahan DE,Yazlovitskaya EM

    更新日期:2008-07-15 00:00:00

  • Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

    abstract::The standard systemic treatment for prostate cancer (PCa) is androgen ablation, which causes tumor regression by inhibiting activity of the androgen receptor (AR). Invariably, PCa recurs with a fatal androgen-refractory phenotype. Importantly, the growth of androgen-refractory PCa remains dependent on the AR through v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0594

    authors: Dehm SM,Schmidt LJ,Heemers HV,Vessella RL,Tindall DJ

    更新日期:2008-07-01 00:00:00

  • Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

    abstract::Resistance of human renal cell carcinoma (RCC) and melanoma to the apoptosis-inducing effects of IFNs was postulated to result from epigenetic silencing of genes by DNA methylation, a common feature of human cancers. To reverse silencing, 5-AZA-deoxycytidine (5-AZA-dC) or selective depletion of DNA methyltransferase 1...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2303

    authors: Reu FJ,Leaman DW,Maitra RR,Bae SI,Cherkassky L,Fox MW,Rempinski DR,Beaulieu N,MacLeod AR,Borden EC

    更新日期:2006-03-01 00:00:00

  • Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.

    abstract::Mice bearing the immunosuppressive plasmacytoma TEPC-183 exhibit a marked splenic hyperplasia. We have characterized these tumor-reactive splenocytes on the basis of cell surface marker expression, nonspecific esterase activity, and morphology. Although splenocyte numbers increased progressively throughout tumor growt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shanahan TC,Ceglowski WS,Havas HF

    更新日期:1985-12-01 00:00:00

  • Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

    abstract::Promoter hypermethylation and histone deacetylation are common epigenetic mechanisms implicated in the transcriptional silencing of tumor suppressor genes in human cancer. We treated two immortalized glioma cell lines, T98 and U87, and 10 patient-derived primary glioma cell lines with trichostatin A (TSA), a histone d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4453

    authors: Foltz G,Ryu GY,Yoon JG,Nelson T,Fahey J,Frakes A,Lee H,Field L,Zander K,Sibenaller Z,Ryken TC,Vibhakar R,Hood L,Madan A

    更新日期:2006-07-01 00:00:00

  • Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters.

    abstract::The ability of the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), to induce chemotaxis in three different populations of mouse peritoneal macrophages was studied. TPA in the range of 10(-9) to 10(-7) M produced a dose- and time-related increase in chemotaxis in resident, thioglycollate-elicited, and divin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Laskin DL,Laskin JD,Weinstein IB,Carchman RA

    更新日期:1981-05-01 00:00:00

  • Identification of an enhancer responsible for tumor marker gene expression by means of transgenic rats.

    abstract::The glutathione transferase P (GST-P) gene is known for its specific expression during chemical hepatocarcinogenesis of the rat and is used as a tumor marker for hepatocellular carcinoma. We have shown recently that the upstream 2.9-kb region of the GST-P gene is sufficient for conferring tumor-specific expression of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki T,Imagawa M,Hirabayashi M,Yuki A,Hisatake K,Nomura K,Kitagawa T,Muramatsu M

    更新日期:1995-06-15 00:00:00

  • Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.

    abstract::Metastatic nonseminomatous testicular germ cell tumors are curable using combination chemotherapy in approximately 80% of patients. In contrast, most other patients with other types of cancer either present with or acquire drug-resistant disease following chemotherapy. Cell lines derived from testis tumors retain hype...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parris CN,Walker MC,Masters JR,Arlett CF

    更新日期:1990-12-01 00:00:00

  • Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjects.

    abstract::Erythrocytes containing micronuclei serve as an indicator of genotoxic exposure in splenectomized individuals. Micronucleated erythrocytes, derived from cytogenetically damaged RBC precursors, are not selectively removed from peripheral blood in individuals who lack splenic function. The relationship between micronucl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith DF,MacGregor JT,Hiatt RA,Hooper NK,Wehr CM,Peters B,Goldman LR,Yuan LA,Smith PA,Becker CE

    更新日期:1990-08-15 00:00:00

  • Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.

    abstract::The regulation of cyclic adenosine 3:5-monophosphate (cyclic AMP) phosphodiesterase activity in homogenates of malignant and cyclic AMP-induced "differentiated" neuroblastoma cells was studied. Neuroblastoma cells of at least three mouse and one human clone had both the low (2 to 4 muM) and the high (66 to 106 muM) Km...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kumar S,Becker G,Prasad KN

    更新日期:1975-01-01 00:00:00

  • Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.

    abstract::The binding of tritium-labeled 5-methylchrysene to DNA of CD-1 mouse skin 24 hr after treatment has been studied. DNA was isolated from the treated skin areas of mice and hydrolyzed enzymatically to deoxyribonucleosides, and the hydrolysate was chromatographed on a Sephadex LH-20 column using a methanol:water gradient...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Melikian AA,LaVoie EJ,Hecht SS,Hoffmann D

    更新日期:1982-04-01 00:00:00

  • Molecular interactions of the combined effects of bleomycin and x-rays on mammalian cell survival.

    abstract::The interactions between bleomycin and X-ray damage and repair have been examined in rat and human tumor cells. Bleomycin itself indices extensive DNA single-strand breaks but does not appear to inhibit the repair of X-ray-induced DNA single-strand breaks. Quantitative analysis of these interactions is complicated by ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Byfield JE,Lee YC,Tu L,Kulhanian F

    更新日期:1976-03-01 00:00:00

  • Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole.

    abstract::Fischer X Copenhagen rats bearing Dunning R3327-AT tumors were treated with hematoporphyrin derivative and red light (630 nm from an argon-driven dye laser) alone or in combination with the hypoxic cell radiosensitizer, misonidazole (MISO). In vitro studies had suggested that hypoxia might significantly decrease the c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gonzalez S,Arnfield MR,Meeker BE,Tulip J,Lakey WH,Chapman JD,McPhee MS

    更新日期:1986-06-01 00:00:00

  • Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

    abstract::One of the major problems in the diagnosis of localized prostatic tumors is to predict the aggressiveness of an individual tumor, which is presumably associated with chance to progression. In an attempt to find molecular markers that are specific for aggressive prostatic cancer cells, we compared steady-state mRNA lev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bussemakers MJ,van de Ven WJ,Debruyne FM,Schalken JA

    更新日期:1991-01-15 00:00:00

  • Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252.

    abstract::Experiments were carried out to determine if the difference in rates of cell proliferation between normal and neoplastic cells may be related to altered levels of oxidative enzymes. Assays were performed using homogenates from hepatocellular carcinoma HC-252, a rapidly growing and moderately well-differentiated tumor;...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sun AS,Cederbaum AI

    更新日期:1980-12-01 00:00:00

  • Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.

    abstract::Using a sensitive radioimmunoassay, concentrations of vincristine and its products were determined in cerebrospinal fluid (CSF) and corresponding blood samples from four patients with lymphoma and two patients with leukemia who had received i.v. bolus injection of 2 mg vincristine. Serial samples of CSF were withdrawn...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jackson DV Jr,Sethi VS,Spurr CL,McWhorter JM

    更新日期:1981-04-01 00:00:00

  • Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

    abstract::Type beta transforming growth factor-growth inhibitor (TGF beta/GI) causes normal human prokeratinocytes to arrest growth predominantly in the G1 phase of the cell cycle within 48 h after log phase cultures are exposed to the factor in serum-free medium. The growth arrest induced by TGF beta/GI is reversible because t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shipley GD,Pittelkow MR,Wille JJ Jr,Scott RE,Moses HL

    更新日期:1986-04-01 00:00:00

  • Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.

    abstract::To better understand the events occurring during immunotherapy of liver metastases with effector cells, we have developed a clinically relevant animal model in which both effector-tumor cell interactions and survival can be evaluated. A cell line of human gastric carcinoma (HR) metastatic to the liver has been establi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yasumura S,Lin WC,Hirabayashi H,Vujanovic NL,Herberman RB,Whiteside TL

    更新日期:1994-07-15 00:00:00

  • Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.

    abstract::Fluorescein-labeled dextrans (FITC-D) from 3 to 5000 kDa (Stokes' radii from 1 to 40 nm) were used to study influx from the plasma into the peritoneum and efflux from the peritoneal cavity into the plasma in normal and ascites tumor-bearing mice and in mice whose peritoneal vessels had been rendered hyperpermeable by ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nagy JA,Herzberg KT,Masse EM,Zientara GP,Dvorak HF

    更新日期:1989-10-01 00:00:00

  • Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

    abstract::Alkyl-lysophospholipids have been shown to possess antitumoral activity in animal and in human tumors. Among them, racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine (ET-18-OCH3) had an antimetastatic effect in experimental tumors. We investigated the effect of ET-18-OCH3 on invasion of MO4 mouse fibrosarcoma ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Storme GA,Berdel WE,van Blitterswijk WJ,Bruyneel EA,De Bruyne GK,Mareel MM

    更新日期:1985-01-01 00:00:00

  • A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

    abstract::AS1411 is a first-in-class anticancer agent, currently in phase II clinical trials. It is a quadruplex-forming oligodeoxynucleotide that binds to nucleolin as an aptamer, but its mechanism of action is not completely understood. Mechanistic insights could lead to clinically useful markers for AS1411 response and to no...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0920

    authors: Reyes-Reyes EM,Teng Y,Bates PJ

    更新日期:2010-11-01 00:00:00

  • Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.

    abstract::A new human myeloma cell line, OPM-6, was established from the peripheral blood of a patient with advanced IgG-kappa plasma cell leukemia. Cytogenetic and phenotypic analysis confirmed that the cells were derived from the patient's leukemic cells. Insulin-like growth factor-1 (IGF-1) acts as an autocrine growth factor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ogawa M,Nishiura T,Oritani K,Yoshida H,Yoshimura M,Okajima Y,Ishikawa J,Hashimoto K,Matsumura I,Tomiyama Y,Matsuzawa Y

    更新日期:2000-08-01 00:00:00

  • Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.

    abstract::A translationally regulated, dominant-negative isoform of CCAAT/enhancer-binding protein beta is expressed in transplantable and primary mouse mammary tumors of different etiologies but is not expressed in preneoplastic mammary hyperplasias or in primary prostate, lung, lens, ovary or lymphoid tumors. The eukaryotic i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Raught B,Gingras AC,James A,Medina D,Sonenberg N,Rosen JM

    更新日期:1996-10-01 00:00:00

  • The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

    abstract::The proto-oncogene MET is aberrantly activated via overexpression or mutation in numerous cancers, making it a prime anticancer molecular target. However, the clinical success of MET-directed tyrosine kinase inhibitors (TKI) has been limited due, in part, to mutations in the MET kinase domain that confer therapeutic r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1156

    authors: Miyajima N,Tsutsumi S,Sourbier C,Beebe K,Mollapour M,Rivas C,Yoshida S,Trepel JB,Huang Y,Tatokoro M,Shinohara N,Nonomura K,Neckers L

    更新日期:2013-12-01 00:00:00

  • Restriction of carcinogen-induced error incorporation during in vitro DNA synthesis.

    abstract::The in vitro accuracy of DNA replication has been investigated through the measurement of the frequency with which noncomplementary nucleotides were incorporated during polynucleotide replication. The effect of beta-propiolactone treatment of deoxynucleotide templates, ribopolynucleotide templates, and the DNA polymer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sirover MA,Loeb LA

    更新日期:1976-02-01 00:00:00

  • Cell cycle phase-specific cytotoxicity of the antitumor agent maytansine.

    abstract::The objective of this investigation was to study the effects of maytansine on the cell cycle kinetics of HeLa cells. The results of this study indicate that maytansine is a very potent mitotic inhibitor and that it has no effect on macromolecular synthesis. Maytansine-induced cytotoxicity was dependent upon the positi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rao PN,Freireich EJ,Smith ML,Loo TL

    更新日期:1979-08-01 00:00:00

  • Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.

    abstract::Lung carcinoma cell lines were analyzed in culture and in nude mouse xenograft for both morphological appearance and expression of specific proteins that participate in cross-linked envelope formation during normal squamous cell terminal differentiation. Cross-linked envelope formation, induced by artificial influx of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Levitt ML,Gazdar AF,Oie HK,Schuller H,Thacher SM

    更新日期:1990-01-01 00:00:00